Address: Avenida Americo Vespucio
Sur 100 Of. 401
Piso 04
Las Condes, Santiago Chile
Tel: +56-2-655-8800
In Chile, Merck & Co. Inc is known as Merck Sharp & Dohme (MSD, Chile). Merck Sharp & Dohme Chile began operations on 1 May 1995. The company has established itself as an international company constantly seeking the promotion of health, safety and welfare of its customers, employees, the community and other groups in society. Operations involve the distribution, marketing, sales and clinical research by professionals located in Santiago and other major cities.
MSD Chile currently is organized into three divisions: MHHD (Merck Human Health Division), MRL (Merck Research Laboratories) and MMD (Merck Manufacturing Division), with approximately 124 employees. MSD Chile is recognized in the industry and the medical community for its integrity, transparency and ethical business practices and values that are shared globally by all employees of the corporation.
Likewise, for the 4th consecutive year, Merck Sharp & Dohme Chile has been chosen among the 25 best companies to work for by the Institute ‘Great Place to Work” , which in 2004 recognized MSD as the fourth-best company to work for in Chile, based on the an employee satisfaction survey in several companies.
Chronic diseases; asthma, arthritis, hypertension, osteoporosis, hypercholesterolemia, glaucoma.
What have been MSD’s major milestones and achievements since your establishment in Chile in 1995? We have recently gone through a global merger with Schering Plough, which occurred exactly a…
Eduardo Loyola has been at the helm of Heel’s Chilean affiliate for almost a decade. Prior to his appointment at Heel, Loyola was part of a working group that is…
Medtronic, world’s largest medical technology company, opened a direct operation in Chile in October 2013. Gonzalo Valdebenito elaborates on the affiliate’s first steps in the country and the mission he…
Cells for Cells is the first Chilean biotechnology company engaged in the research, development and commercialization of innovative cell therapies based on adult stem cells. In line with the company’s…
“We have implemented a strategic plan with a key objective to put Chile on the map. We are seeing major market opportunities in the country”, says Carlos Cicogna, Managing Director,…
Ciro Caravaggio, General Manager at Roche Chile discusses Roche’s mission as a highly specialized biotech with a long presence in Chile. He stresses the importance of the affiliate’s role in…
Raúl Sánchez, general manager of Peri Logistics speaks about the main features that distinguish Peri Logistics as a pharmaceutical logistics operator. Celebrating its 10th year anniversary this year, the company…
João Simões, Head of Integration at Grunenthal Chile, discusses Grunenthal’s acquisition of Andrómaco Laboratories. The acquisition has been a major step in Grunenthal’s growth strategy and has almost doubled its…
“70 percent of products on the Chilean market cannot demonstrate quality, safety and efficacy through bioequivalence studies”, explains Jean Jacques Duhart, Vicepresidente Ejecutivo of the association that represents the innovative…
Rodrigo Azócar Ibaceta, general manager at Laboratorios Raffo Chile speaks about Raffo’s development on the Chilean market. Part of the prestigious GP Pharm’s group, Raffo is one of the fastest…
Erich Viertel Molina, country manager at Janssen Chile speaks about Janssen’s commitment to the health of Chileans. Over the past years Janssen successfully launched several products to the Chilean market…
Pfizer will invest in a precision medical center studying new genome-based diagnostic technologies for cancer in Chile. It is the first center of excellence that Pfizer is building in Chile…
Our business model is new in the Chilean market and enables us with great flexibility and allows us to focus on demand generation. For Ferrer this is a great window…
See our Cookie Privacy Policy Here
